Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04264845 · ClinicalTrials.gov registry record
Patient-Reported Outcomes as an Indicator of Disease Transitions in Heart Failure
A clinical trial of Heart Failure, sponsored by Intermountain Health Care.
- Active
- Registry status
- 3,640
- Enrollment target
- 1
- Study location
NCT04264845: Active study of Heart Failure, sponsored by Intermountain Health Care.
NCT04264845 is a study of Heart Failure that is active but no longer recruiting, run by Intermountain Health Care. The registered enrollment target is 3,640 participants, above the 2,040-participant average among 397 other Heart Failure trials with a reported enrollment target (78% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04264845, a study of Heart Failure, is active but no longer recruiting, sponsored by Intermountain Health Care.
- ACTIVE NOT RECRUITING
- Registry status
- 3,640 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, observational, open study that will utilize the following tools: survey/questionnaire research, interviews, and focus groups, and secondary/archival data analysis. In addition, a subset of selected subjects will be asked to provide blood samples to examine the biologic determinants of patient health status in heart failure (HF). This will help us understand better the biomarkers or genetic factors that may cause differences in patient quality of life.
Conditions Studied
Interventions
- OTHER Provider Focus
- OTHER Patient Interview
- OTHER PROs/Clinical Data Integration
Study Locations (1)
Utah
- Intermountain Heart Institute - Murray
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,640 participants |
| Start Date | 2019-12-01 |
| Est. Completion | 2026-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04264845
The ClinicalTrials.gov registry entry for NCT04264845 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 3,640 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,040-participant average among 397 other Heart Failure trials with a reported enrollment target (78% higher). The listed sponsor is Intermountain Health Care, which has 85 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 3 interventions - of which Provider Focus is the first listed.
NCT04264845 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT04264845 about?
NCT04264845 is a clinical study titled "Patient-Reported Outcomes as an Indicator of Disease Transitions in Heart Failure". This is a prospective, observational, open study that will utilize the following tools: survey/questionnaire research, interviews, and focus groups, and secondary/archival data analysis. In addition, a subset of selected subjects will be asked to provide blood samples to examine the biologic determi...
What is the current status of trial NCT04264845?
This trial is currently active not recruiting. The enrollment target is 3,640 participants. The study started on 2019-12-01. Estimated completion is 2026-03.
What conditions does trial NCT04264845 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT04264845?
The interventions under investigation include: Provider Focus (OTHER), Patient Interview (OTHER), PROs/Clinical Data Integration (OTHER).
Who is sponsoring clinical trial NCT04264845?
This trial is sponsored by Intermountain Health Care, which has 85 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04264845 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.